Mohammad Al-Hanaktah

Dr. Mohammad Al-Hanaktah

orcid

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 January 2025 in Viruses
Verified
Journal Article
Open access
PDF file
MAMunir Abu-Helalah
Munir Abu-Helalah
MLMohammad Abu Lubad
Mohammad Abu Lubad
MAMohammad Al-Hanaktah
Mohammad Al-Hanaktah
ATAhmad Al Tibi
Ahmad Al Tibi
MAMaisalreem Alhousani
Maisalreem Alhousani
SDSimon Drysdale
Simon Drysdale
Human parainfluenza virus (HPIV) is a major cause of respiratory illnesses in children under five years, with clinical manifestations ranging from mild upper respiratory tract infections to severe lower respiratory tract diseases. This multi-center, cross-sectional study investigated the burden, clinical features, and predictors of respiratory viral infections in hospitalized children across four sites in Jordan. Nasopharyngeal specimens from 1000 eligible children were analyzed. In this article, we focused on HPIV infections. The overall HPIV positivity rate was 22.6%, with HPIV-3 accounting for 90.3% of cases. Significant geographic variability was observed, with higher positivity rates in the southern region. HPIV-positive cases frequently presented with symptoms like nasal congestion, tachypnea, and poor feeding. Co-infections with respiratory syncytial virus (RSV) or influenza were associated with worse outcomes, including an increased need for invasive ventilation. The logistic regression identified male gender, asthma, and respiratory acidosis as predictors of complications. Geographic differences in HPIV prevalence and severity were notable, emphasizing the influence of environmental and socioeconomic factors. These findings underscore the urgent need for enhanced HPIV surveillance, targeted public health interventions, and vaccine development to mitigate the disease burden. This study provides critical insights that guide healthcare strategies and improve outcomes in young children at risk of severe HPIV infections.


26 December 2024 in Vaccines
Verified
Journal Article
Open access
PDF file
MAMunir Abu-Helalah
Munir Abu-Helalah
SASamah Al-Shatnawi
Samah Al-Shatnawi
MLMohammad Abu Lubad
Mohammad Abu Lubad
EZEnas Mohammad Salameh Al Zayadneh
Enas Mohammad Salameh Al Zayadneh
MAMohammad Al-Hanaktah
Mohammad Al-Hanaktah
ONOmar Nafi
Omar Nafi
Background/Objectives: Seasonal influenza is a significant global health concern, causing substantial morbidity and mortality, particularly among high-risk groups such as children under five years old. There is scarce local evidence from developing countries such as Jordan on the burden of influenza, which has limited preventive measures. This multi-center national cross-sectional study aimed to assess the epidemiological and clinical burden of influenza among hospitalized children under five years old in Jordan. Methods: Data were collected from 1000 participants across four hospitals between November 2022 and April 2023. Nasopharyngeal specimens were analyzed using multiplex RT-PCR to determine positivity for influenza A and B. Results: We found a 9.9% positivity rate, predominantly influenza A (8.4%), while influenza B was positive among 1.5% of the participants. Positivity rates were higher in older age groups, particularly children older than 2 years. Influenza-positive cases exhibited longer fever durations and higher rates of sore throat. There were no positive influenza cases among participants if they or any of their family members received the influenza vaccine, highlighting the vaccine’s protective role. Logistic regression analysis identified maternal smoking during pregnancy as a significant predictor of influenza positivity. Conclusions: The findings of this study underscore the need for enhanced vaccination efforts and public health policies targeting young children and pregnant women in Jordan. Expanding vaccination uptake could significantly mitigate the burden of influenza and its complications in this vulnerable population.

17 April 2025 in Italian Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
MAMunir Abu-Helalah
Munir Abu-Helalah
NANadine N. Abdelhadi
Nadine N. Abdelhadi
MAMohammad Al-Hanaktah
Mohammad Al-Hanaktah
AAAmro Asfour
Amro Asfour
MHMea’aD Harahsheh
Mea’aD Harahsheh
LMLekaa Al Mughrabi
Lekaa Al Mughrabi
Vaccination against influenza is the major primary preventive measure to reduce the major health and economic burden of influenza infections. Children aged 6 months to five years, have been identified as the highest risk group for influenza complications, therefore, it is essential to ensure a high uptake rate of influenza vaccine amongst this age group. A structured questionnaire based on the Health Belief Model was used to collect data from parents through face-to-face interview on influenza vaccine uptake among children from 6 months to 5 years of age in Jordan. It also aimed to assess knowledge, attitudes and barriers towards influenza vaccine for this age group. 477 parents completed the study questionnaire. The study revealed a low influenza vaccine uptake rate of 12.0% for the 2022/2023 influenza season. Around one fifth (19.3%) of study participants reported to ever had their child vaccinated against influenza. The study identified several factors motivating parents to get their children vaccinated; such as healthcare professional advice, higher income and history of previous severe influenza infection requiring hospitalization. On the other hand, several barriers related to influenza vaccine were identified; such as cost and concerns about the vaccine safety. There is an overall low uptake of influenza vaccine amongst children in Jordan. There is a need for public health programs and more involvement of the healthcare professionals to improve the reported rates of vaccination from Jordan. This is in addition to focusing these programs on reported barriers for the influenza vaccine uptake.

6 June 2025 in Annals of Medicine
Verified
Journal Article
Open access
MAMunir Abu-Helalah
Munir Abu-Helalah
AAAmro Asfour
Amro Asfour
MAMary Almadani
Mary Almadani
MAMay Alfayyadh
May Alfayyadh
SHSereen Halayqeh
Sereen Halayqeh
IAIsraa Al-Rawashdeh
Israa Al-Rawashdeh
Breast cancer in Jordan accounts for 37.5% of all cancers in females. With the absence of regular systematic screening for breast cancer in Jordan, work is focused mainly on health promotion campaigns. This study assessed the screening uptake, identified barriers, and examined women’s awareness of the importance of mammography screening in Jordan. This cross-sectional survey was conducted in six governorates in Jordan. Data was collected through face-to-face interviews with a random sample of women aged 40 to 69 years who were eligible for mammography screening. 610 participants with a mean age of 50.35 ± 7.6 years were included in the study. Breast self-examination, doctor examination, and periodic mammography screening were reported by 33.6%, 13.8%, and 10.4% of study participants, respectively. High income and family history of breast cancer were statistically significant predictors of screening. This study identified key barriers to screening such as cost and limited healthcare professionals’ advice. In the absence of a national program for free systematic screening for breast cancer in Jordan, the uptake of mammography screening is expected to stay at low rates. The outcomes of the study will assist future campaigns and programs for improving the uptake of breast cancer screening in Jordan.

22 October 2025 in The Pediatric Infectious Disease Journal
Verified
Journal Article
Closed access
MAMunir Abu-Helalah
Munir Abu-Helalah
MAMohammad Al-Hanaktah
Mohammad Al-Hanaktah
MLMohammad Abu Lubad
Mohammad Abu Lubad
ATAhmad Al Tibi
Ahmad Al Tibi
MAMaisalreem Alhousani
Maisalreem Alhousani
SDSimon Drysdale
Simon Drysdale
Background: Human Adenovirus (HAdV) is a significant pathogen associated with severe acute respiratory infections, especially in children under 5. Despite its global impact, its epidemiological and clinical burden in Jordan, particularly post-COVID-19, is limited. Methods: We conducted a multicenter cross-sectional study across 4 hospitals in Jordan from November 2022 to April 2023. Nasopharyngeal swabs were collected from children <5 years old hospitalized with respiratory symptoms. HAdV positivity was determined using real-time polymerase chain reaction. Demographic, clinical and laboratory data were analyzed to identify predictors of HAdV positivity and complications. Results: Among 1000 enrolled participants (median age 9.68 months, 59% male), the HAdV positivity rate was 10.9%, highest in children 49–60 months of age. HAdV-positive cases had higher rates and longer duration of sore throat compared with HAdV-negative cases. Coinfections with respiratory syncytial viruses or influenza were present in 34.9% of HAdV-positive cases and were associated with increased rates of cough, wheezing and respiratory crackles. Logistic regression revealed lower odds of HAdV positivity in children under six months [odds ratio (OR) 0.31, P < 0.001], while invasive ventilation was associated with higher odds of positivity (OR 5.01, P < 0.001). HAdV infection without coinfection was associated with reduced odds of complications (OR 0.06, P < 0.001). Conclusions: This is the first comprehensive study in Jordan to document the epidemiologic and clinical burden of HAdV in children post-COVID-19. HAdV remains a major cause of respiratory morbidity, with significant coinfection rates. Further research is needed to explore the nonrespiratory manifestations, identify HAdV common local serotypes and genetic characteristics.